Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,426.49 1.64 0.01%
S&P 500 1,866.71 4.40 0.24%
NASDAQ 4,100.76 14.53 0.36%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Pfizer and Boehringer Ingelheim Pharmaceuticals to feature in line up at Smithers Rapra Extractables and Leachables USA



  Pfizer and Boehringer Ingelheim Pharmaceuticals to feature in line up at
  Smithers Rapra Extractables and Leachables USA Conference 2013

 2^nd Extractables and Leachables conference held in USA in Providence, RI on
                                May 7-9 2013.

Business Wire

PROVIDENCE, R.I. -- February 6, 2013

Extractables and Leachables USA 2013 (E&L USA) have released their full agenda
for 2013. The 3 day event will feature a pre-conference workshop, poster
sessions and a 2 day speaker program covering case studies on materials
composition and quality, toxicological perspectives on E&Ls and challenges in
E&L studies.

Smithers Rapra’s annual Extractables and Leachables conferences attract a wide
range of delegates. E&L USA 2012 was attended by an expanse of companies from
pharmaceutical manufacturers, medical device manufacturers, packaging and
materials suppliers to CROs, government and academia. Last year over 65
delegates visited the conference, the full list of attending companies can be
found here.

E&L USA 2013 will cover the latest developments from industry practitioners
and working groups to meet regulatory requirements and ensure compatibility in
drug-package combinations. Speakers lined up include Dennis Jenke, Baxter
Healthcare; Bill Beierschmitt, Pfizer, and Diane Paskiet, West Pharmaceutical
Services.

Dan Norwood, Distinguished Research Fellow, Boehringer Ingelheim
Pharmaceuticals, is one of the keynote speakers for E&L USA and scheduled to
discuss the United States Pharmacopeia and the issue of leachables and
extractables: past, present and future. On current challenges with respect to
E&Ls, Norwood commented “the most significant current challenge for the entire
pharmaceutical landscape is reaching consensus among all of the various
stakeholders regarding how to address the key issues related to E&Ls for all
drug product types and medical devices.”

Further highlights of the conference include case studies from Johnson &
Johnson, EMD Millipore and BD Medical on biodegradable and permanent
implantable devices, single-use systems and elastomeric components for
parenteral packaging. Plus the pre-conference workshop, led by Dr Andrew
Feilden, Chemistry Operations Director and Sukhy Toot, Product Manager -
Medical Devices at Smithers Rapra, will cover an introduction to extractables
and leachables, material selection, risk based analysis and extractable and
leachable testing. And, new for 2013, poster sessions will allow attendees to
hear even more about recent research and findings relating to all areas of
E&Ls.

For more information on E&L USA 2013 conference visit
http://www.eandl-conference.com

To find out more information Smithers Rapra visit
http://www.smithersrapra.com/

Contact:

Smithers Rapra
Jo Martin
+44 (0)1372 802000
Jomartin@smithers.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement